标题:Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with an Indole-Containing Cap Group
作者:Yingjie Zhang;Penghui Yang;C. James Chou
作者机构:[Zhang, Y] Department of Medicinal Chemistry, School of Pharmacy, Shandong University, Ji'nan, Shandong, 250012, China;[ Yang, P] Department of Medici 更多
通讯作者:Xu, WF
通讯作者地址:[Xu, WF]Shandong Univ, Sch Pharm, Dept Med Chem, Jinan 250012, Shandong, Peoples R China.
来源:ACS medicinal chemistry letters
出版年:2013
卷:4
期:2
页码:235-238
DOI:10.1021/ml300366t
关键词:histone deacetylases;inhibitor;N-hydroxycinnamamide;indole
摘要:A novel series of histone deacetylase inhibitors combining Nhydroxycinnamamide bioactive fragment and indole bioactive fragment was designed and synthesized. Several compounds (17c, 17g, 17h, 17j, and 17k) exhibited comparable, even superior, total HDACs inhibitory activity and in vitro antiproliferative activities relative to the approved drug SAHA. A representative compound 17a with moderate HDACs inhibition was progressed to isoform selectivity profile, Western blot analysis, and in vivo antitumor assay. Although HDACs isoform selectivity of 17a was similar to that of SAHA, our Western blot results indicated that intracellular effects of 17a at 1 μM were class I selective. It was noteworthy that the effect on histone H4 acetylation of SAHA decreased with time, while the effect on histone H4 acetylation of 17a was maintained and even increased. Most importantly, compound 17a exhibited promising in vivo antitumor activity in a U937 xenograft model.
收录类别:SCOPUS;SCIE
WOS核心被引频次:20
Scopus被引频次:23
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873975114&doi=10.1021%2fml300366t&partnerID=40&md5=c85836855184699f25d00b7ce53bbdd4
TOP